BNP Paribas Financial Markets
CMMB

BNP Paribas Financial Markets’s Chemomab Therapeutics CMMB Stock Holding History

BNP Paribas Financial Markets’s Portfolio CMMB Stock Details CMMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.2K Buy
8,425
+300
+4% +$513 ﹤0.01% 5168
2025
Q4 		$13.4K Buy
8,125
+2,375
+41% +$6.3K ﹤0.01% 5108
2025
Q3 		$15.1K Buy
5,750
+2,275
+65% +$8.39K ﹤0.01% 4948
2025
Q2 		$16.1K Buy
3,475
+850
+32% +$4.21K ﹤0.01% 4694
2025
Q1 		$11.4K Buy
2,625
+1,000
+62% +$7.01K ﹤0.01% 4687
2024
Q4 		$11.8K Buy
+1,625
New +$10.3K ﹤0.01% 4825

Other funds holding CMMB

ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $8.11B AUM 24.74% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $240M AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
PIP
Philadelphia Investment Partners Voorhees, New Jersey $147M AUM
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return